B. J. Warude Et Al. , "Design, docking, MD simulation and in-silco ADMET prediction studies of novel indolebased benzamides targeting estrogen receptor alfa positive for effective breast cancer therapy," Pharmacia , vol.70, no.2, pp.307-316, 2023
Warude, B. J. Et Al. 2023. Design, docking, MD simulation and in-silco ADMET prediction studies of novel indolebased benzamides targeting estrogen receptor alfa positive for effective breast cancer therapy. Pharmacia , vol.70, no.2 , 307-316.
Warude, B. J., Wagh, S. N., Chatpalliwar, V. A., YILDIRIM, M., ÇELİK, İ., Rudrapal, M., ... Khan, J.(2023). Design, docking, MD simulation and in-silco ADMET prediction studies of novel indolebased benzamides targeting estrogen receptor alfa positive for effective breast cancer therapy. Pharmacia , vol.70, no.2, 307-316.
Warude, Bhagyashri Et Al. "Design, docking, MD simulation and in-silco ADMET prediction studies of novel indolebased benzamides targeting estrogen receptor alfa positive for effective breast cancer therapy," Pharmacia , vol.70, no.2, 307-316, 2023
Warude, Bhagyashri J. Et Al. "Design, docking, MD simulation and in-silco ADMET prediction studies of novel indolebased benzamides targeting estrogen receptor alfa positive for effective breast cancer therapy." Pharmacia , vol.70, no.2, pp.307-316, 2023
Warude, B. J. Et Al. (2023) . "Design, docking, MD simulation and in-silco ADMET prediction studies of novel indolebased benzamides targeting estrogen receptor alfa positive for effective breast cancer therapy." Pharmacia , vol.70, no.2, pp.307-316.
@article{article, author={Bhagyashri J. Warude Et Al. }, title={Design, docking, MD simulation and in-silco ADMET prediction studies of novel indolebased benzamides targeting estrogen receptor alfa positive for effective breast cancer therapy}, journal={Pharmacia}, year=2023, pages={307-316} }